New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about amylin analogs, retatrutide and more.
A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets ...
(Removes reference to GLP-1s in reference to Lilly Direct patients in paragraph 15,) By Maggie Fick and Michael Erman SAN FRANCISCO, Jan 12 (Reuters) - Eli Lilly's research and development head said ...
"I'm a whole new person." Read Molly's inspiring success story about ESG, a minimally invasive weight loss solution from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results